Clinical Trials Browser

Fallopian Tube Neoplasms, Ovarian Neoplasms, Vaccinia

Locally Advanced Cervical Adenocarcinoma

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Endometrial Neoplasms

Appendiceal Neoplasms, Gastrointestinal Neoplasms, Necrosis, Ovarian Neoplasms, Peritoneal Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Ovarian Neoplasms, Uterine Neoplasms

Uterine Cervical Neoplasms

Advanced Cervical Cancer

Vulvar Neoplasms

Peritoneal Neoplasms, Stomach Neoplasms

Peritoneal Neoplasms, Adrenocortical Carcinoma

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Uterine Cervical Neoplasms

Female, Age ≥ 18 Years Old

Biliary Tract Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Ovarian Neoplasms

Uterine Cervical Neoplasms, Recurrence

Locally Advanced Cervical Cancer

Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, Neoplasms

Uterine Cervical Neoplasms, Endometrial Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Endometrial Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Locally Advanced Cervical Cancer

Uterine Cervical Neoplasms

Lymphatic Metastasis, Vulvar Neoplasms

Ovarian Germ Cell Cancer, Ovarian Neoplasms

Clinical Trials

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

TroFuse-036

Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer

HOTT

Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer

Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC

A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer

Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer

Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

SCENIC

SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer

MICHELE

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

PARCERII

Neoadjuvant Therapy in Cervical Cancer

Neoadjuvant Immunochemotherapy in PD-L1-negative LACC

RAINBO

Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer

Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC

Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer

AddChemo

Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma

Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC

ONCOCOL01

GROINSS-VIII

MOGCT-01